XENE.OQ - Xenon Pharmaceuticals Inc
Wells Fargo Securities, LLC
XENE: We Remain Constructive that X-TOLE2 Will Be Positive and Exhibit a Similar Efficacy Profile as Ph2 (4Q25 Update)
公司
XENE.OQ
日期
2026-02-26
分析师
Mr. Benjamin J. Burnett, PHD
页数
8 页
需要登录
请登录后购买研报或生成音频内容。